STRENSIQ may cause serious side effects,
including
- Serious allergic (hypersensitivity) reactions happened
in some people who
use
STRENSIQ. Stop using STRENSIQ and go to the nearest hospital emergency
room right away if you
or
your loved one have any of the signs and symptoms of a serious allergic
reaction, including
- Difficulty breathing
- Swelling of your eyes, lips, or tongue
- Hives
- Feeling faint
- Nausea or vomiting
- Dizziness
- Itching of your lips, tongue, or throat
- Choking sensation
- Skin thickening or pits at the injection site
(lipodystrophy) has happened
several months after using STRENSIQ.
- Calcium buildup in the eyes and kidneys can occur if
you or your loved one
have HPP. Your healthcare provider should check the eyes and kidneys
while you or your loved
one
use STRENSIQ.
- Decreased efficacy. Contact your healthcare provider if
you or your loved
one
notice STRENSIQ is no longer working or experience worsening symptoms of
HPP (e.g., increased
respiratory support, increased difficulty walking, new fractures).
The most common side effects of STRENSIQ include local skin
injection-site
reactions (red skin patches, bruising, color change, pain, itching,
thinning, swelling, pits,
and
bumps) and calcium buildup in your eyes and kidneys.
STRENSIQ may affect other lab test results, therefore it is
important that you
present your Medical Alert Card to your healthcare team so they are aware
that you are being
treated with an alkaline phosphatase (ALP) replacement therapy which may
cause incorrect results
on certain laboratory tests.
Tell your doctor if you are pregnant or plan to become pregnant or are
breastfeeding or plan to
breastfeed.
These are not all the possible side effects of STRENSIQ. For more
information, ask your
healthcare provider or pharmacist. Call your healthcare provider for medical
advice about side
effects. You may report side effects to the US Food and Drug Administration
at 1‑800‑FDA‑1088.
INDICATION
What is STRENSIQ?
STRENSIQ is a prescription medicine used to treat people with
perinatal/infantile- and
juvenile-onset hypophosphatasia (HPP).